Selnoflast

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameSelnoflast
Drug Alias NameNLRP3iSomalixSOMALIXSelnoflast potassiumRG-6418 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsInflammationCryopyrin-Associated Periodic SyndromesAtherosclerosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInflazome
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche LtdGenentech Inc
Inactive CompaniesInflazome Uk Ltd
Active IndicationsInflammationAtherosclerosisParkinson Disease +[6] 
Inactive IndicationsCryopyrin-Associated Periodic Syndromes

Other Information

ATC CodeN/A
Related LinksN/A